The House Select Committee on the Chinese Communist Party (CCP) has asked the Department of Justice to review a D.C.-based trade group that allegedly lobbies on behalf of a CCP-linked biotech company.
In a letter dated March 5 to Attorney General Merrick Garland, Rep. Mike Gallagher (R-Wis.), the committee’s Chairman, raised concerns regarding the Biotechnology Innovation Organization (BIO), a trade association representing the biotechnology industry, and its lobbying effort against the BIOSECURE Act. This legislation aims to prevent federally funded providers from benefiting Chinese biotech firms, including WuXi AppTec.
“BIO’s advocacy on behalf of WuXi AppTec raises concerns that it is operating as an unregistered agent of a foreign principal while advancing the interests of the People’s Republic of China (PRC) government and the Chinese Communist Party (CCP),” Mr. Gallagher wrote….